COLON CARCINOMA
Clinical trials for COLON CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLON CARCINOMA trials appear
Sign up with your email to follow new studies for COLON CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New algorithm aims to stop chemotherapy delays
Disease control Recruiting nowThis study is testing whether a new, step-by-step dosing guide called the PAGODA algorithm can help prevent unplanned delays in FOLFOX chemotherapy for people with gastrointestinal cancers. About 420 participants will be randomly assigned to have their chemotherapy doses adjusted…
Matched conditions: COLON CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug cocktail aims to shrink colon tumors before surgery
Disease control Recruiting nowThis study is testing whether giving short-term immunotherapy before surgery can help control early-stage colon cancer. Patients receive one of several drug combinations for 6-12 weeks before their tumor is surgically removed. The main goals are to see if the treatment is safe, i…
Matched conditions: COLON CARCINOMA
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Could cannabis ease the agony of chemo nerve damage?
Symptom relief Recruiting nowThis study is testing whether two cannabis-based treatments (CBD alone or a THC:CBD mix) can reduce chronic nerve pain, tingling, and numbness caused by chemotherapy. It will involve 120 breast and colon cancer survivors who have finished treatment but still suffer from these sid…
Matched conditions: COLON CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test 'Tumor Homing' tracers in first human imaging study
Knowledge-focused Recruiting nowThis early study aims to see how two new radioactive tracers travel through the body and gather in tumors. Researchers will give a single, tiny dose of one tracer to up to 32 patients with various solid tumors and then use PET/CT scans to track where it goes. The main goal is to …
Matched conditions: COLON CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Var2 Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC